Wikidata

(Q66396337)

English

Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer

clinical trial

In more languages

Statements

title
A Phase II Study of Pembrolizumab Combined With Pegylated Liposomal Doxorubicin (PLD) For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer (English)
0 references
start time
15 September 2016
0 references
end time
February 2020
0 references
number of participants
26
0 references
research intervention
pembrolizumab
0 references
doxorubicin
0 references
Caelyx
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66396337&oldid=1858867938"